(19)
(11) EP 1 395 680 A2

(12)

(88) Date of publication A3:
16.10.2003

(43) Date of publication:
10.03.2004 Bulletin 2004/11

(21) Application number: 02726302.9

(22) Date of filing: 15.05.2002
(51) International Patent Classification (IPC)7C12Q 1/68, G01N 33/48
(86) International application number:
PCT/GB2002/002294
(87) International publication number:
WO 2002/095069 (28.11.2002 Gazette 2002/48)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 18.05.2001 GB 0112256
24.05.2001 US 292926 P

(71) Applicant: AstraZeneca AB
151 85 Södertälje (SE)

(72) Inventor:
  • MOORE, Rachael
    Macclesfield, Cheshire SK10 4TG (GB)

(74) Representative: Hudson, Janette Mary, Dr. 
AstraZeneca,Global Intellectual Property
151 85 Sodertalje
151 85 Sodertalje (SE)

   


(54) METHODS